Company Filing History:
Years Active: 2014-2016
Title: Innovations by Inventor Xiang-Ming Fang in Immunotherapy
Introduction
Xiang-Ming Fang is an accomplished inventor based in San Diego, CA, recognized for his significant contributions to the field of immunotherapy. With two patents to his name, Fang has developed innovative methods aimed at enhancing immune responses against various antigens, including those related to cancer and infectious agents.
Latest Patents
Fang's latest patents revolve around methods for generating immunity to antigens, providing fundamental advancements in treating diseases. One method includes priming individuals by administering an expression vector that encodes the antigen. This vector contains a transcription unit encoding a secretable fusion protein that comprises both the antigen and a CD40 ligand. The approach enhances the immune response more effectively than administration of the vector alone. Additionally, these methods are applicable for generating immune responses against cancer expressing tumor antigens, such as those associated with mucin or human papillomavirus, as well as infectious agents. Notably, Fang's methods also include the simultaneous production of the expression vector and the fusion protein, reflecting his innovative approach to immunotherapy.
Career Highlights
Xiang-Ming Fang is affiliated with Microvax, LLC, a company focused on biotechnological advancements. Throughout his career, he has remained dedicated to developing cutting-edge solutions in the fight against diseases through immunotherapy.
Collaborations
In his innovative pursuits, Fang collaborates with notable colleagues, including Albert B Deisseroth and Yucheng Tang. Their combined expertise fosters an environment rich in creativity and problem-solving, driving forward the boundaries of vaccine development and immunity generation.
Conclusion
Xiang-Ming Fang's work exemplifies the spirit of innovation in the realm of immunotherapy. His patented methods not only enhance the body's immune response but also hold promise for future treatments in combating cancer and infectious diseases. Through his career at Microvax, LLC and collaboration with esteemed colleagues, Fang continues to pave the way for groundbreaking advancements in medical science.